AstraZeneca
A lab-based Formulation Scientist in late-phase drug development at AstraZeneca focuses on developing commercial oral or inhaled dosage forms with a passion for digital tools. The role involves collaborating within a multidisciplinary team to design, develop, and deliver high-quality clinical and commercial drug product formulations and processes. The position requires applying modelling and simulation approaches alongside hands-on experimental work to drive digital transformation in formulation and process design.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
Scientist, Formulation Development
Integrated Resources INC
Specialist Formulation Development- Nutraceutical/Probiotics
Dr Reddy's Laboratories Limited
Executive - Formulation Development
Apotex Inc
Sr Executive - Formulation Development
Apotex Inc
Formulation and Process Development Scientist
Revolution Medicines
Principal Scientist, Formulation Development (Small Molecules)
Lightspeed Venture Partners